Elicio Therapeutics, Inc. (Nasdaq: ELTX) ('Elicio” or the 'Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced the ...
Bloom Nutrition’s new Sparkling Energy line has exploded, and now drives 60% of all company sales Bloom follows what founder ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
For years, the promise of AI in software engineering has delivered incremental gains. Most organizations have adopted an ...
Immuron Engages Pullan Consulting to Advance IMM-529 Partnering Strategy; Immuron is seeking a partner to support clinical development through regulatory approval and ...
Digital Science, a leading technology company serving stakeholders across the research ecosystem, today announced its forthcoming Dimensions ...
Domino's Pizza's exclusive master franchisee across mainland China, Hong Kong, and Macau, continued store network expansion ...
India's Artificial Intelligence market is entering a new phase of growth. While the first wave focused on AI adoption and awareness, the next phase will be defined by organizations capable of building ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results